FNGU vs XBI
MicroSectors FANG+ Index 3X Leveraged ETN vs SPDR S&P Biotech ETF
- • XBI pays a higher dividend yield (0.35%).
Side-by-side metrics
| Metric | FNGU | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.35% | 0.35% |
Dividend yield Trailing 12-month yield. | 0.00% | 0.35% |
AUM Assets under management — bigger funds are typically more liquid. | $2.08B | $10.92B |
YTD return | -3.17% | 28.80% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.00 | 1.01 |
P/E ratio | 25.73 | — |
Last price | $25.86 | $156.41 |
Inception | — | — |
Issuer | MicroSectors | State Street |
FNGU top holdings
| PLTR | Palantir Technologies Inc Ordinary Shares - Class A | 11.45% |
| MSFT | Microsoft Corp | 10.99% |
| AAPL | Apple Inc | 10.67% |
| AVGO | Broadcom Inc | 10.33% |
| MU | Micron Technology Inc | 10.25% |
| NVDA | NVIDIA Corp | 10.15% |
| AMZN | Amazon.com Inc | 10.07% |
| META | Meta Platforms Inc Class A | 9.43% |
| GOOGL | Alphabet Inc Class A | 8.41% |
| NFLX | Netflix Inc | 8.25% |
XBI top holdings
| MRNA | Moderna Inc | 2.37% |
| NTRA | Natera Inc | 1.82% |
| HALO | Halozyme Therapeutics Inc | 1.77% |
| TWST | Twist Bioscience Corp | 1.77% |
| BIIB | Biogen Inc | 1.75% |
| AMGN | Amgen Inc | 1.73% |
| EXEL | Exelixis Inc | 1.73% |
| UTHR | United Therapeutics Corp | 1.72% |
| ABBV | AbbVie Inc | 1.71% |
| GILD | Gilead Sciences Inc | 1.70% |
About FNGU
FNGU (MicroSectors FANG+ Index 3X Leveraged ETN) is 3x leveraged exposure to FANG+ mega-cap tech names. Managed by MicroSectors, the fund carries $2.1B in assets under management, an expense ratio of 0.35%. Its largest holding is Palantir Technologies Inc Ordinary Shares - Class A (PLTR), which represents 11.5% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 10.1%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.9B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.35%. Its largest holding is Moderna Inc (MRNA), which represents 2.4% of the portfolio. Financial Services is the fund's largest sector exposure at 0.6%.